Oral Anesthetic Liquid
NDC Package 79481-0118-9

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Oral Anesthetic Liquid (benzocaine) liquids is adults and children 2 years of age and older: wipe liquid on with cotton, or cotton swab, or fingertip, apply to the affected area up to 4 times daily or as directed by a doctor/dentistchildren under 12 years of age: adult supervision should be given in the use of this productchildren under 2 years of age: do not usefor denture irritation apply a thin layer to the affected area; do not reinsert dental work until irritation/pain is relieved; rinse mouth well after reinserting. This formulation utilizes a liquid delivery system. Marketed by Meijer, Inc., this product is identified by NDC 79481-0118 and is authorized under FDA application M022.

Identification & Billing

NDC Package Code
79481-0118-9
Package Description
1 BOTTLE in 1 CARTON / 14.7 g in 1 BOTTLE
Product Code
79481-0118
11-Digit Billing Format
79481011809
RxNorm Crosswalk
  • RxCUI: 308657 - benzocaine 20 % Mucous Membrane Topical Solution
  • RxCUI: 308657 - benzocaine 200 MG/ML Mucous Membrane Topical Solution

Clinical Specifications

Proprietary Name
Oral Anesthetic Liquid
Non-Proprietary Name
Benzocaine
Substance Name
Benzocaine
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
BENZOCAINE 20 g/100g
Pharmacologic Class
Usage Information
Adults and children 2 years of age and older: wipe liquid on with cotton, or cotton swab, or fingertip, apply to the affected area up to 4 times daily or as directed by a doctor/dentistchildren under 12 years of age: adult supervision should be given in the use of this productchildren under 2 years of age: do not usefor denture irritation apply a thin layer to the affected area; do not reinsert dental work until irritation/pain is relieved; rinse mouth well after reinserting

Regulatory & Marketing

Labeler Name
Meijer, Inc.
Product Type
Human Otc Drug
FDA Application #
M022
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
02-05-2024
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 79481-0118-9 identifies a specific commercial package of 1 bottle in 1 carton / 14.7 g in 1 bottle of Oral Anesthetic Liquid, a human over the counter drug labeled by Meijer, Inc.. This liquid is formulated for oral use and contains benzocaine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Meijer, Inc. on February 05, 2024. The current certification is valid through December 31, 2026.

How is this Meijer, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 79481011809. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
79481-0118-9
11-Digit CMS (5-4-2)
79481-0118-09

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.